376 related articles for article (PubMed ID: 17950613)
21. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
22. The conundrum of parapsoriasis versus patch stage of mycosis fungoides.
Sarveswari KN; Yesudian P
Indian J Dermatol Venereol Leprol; 2009; 75(3):229-35. PubMed ID: 19439874
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
Gettler SL; Fung MA
Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
[TBL] [Abstract][Full Text] [Related]
24. The head and neck manifestations of mycosis fungoides.
Brennan JA
Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
[TBL] [Abstract][Full Text] [Related]
25. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.
Agar N; Whittaker SJ
Br J Dermatol; 2008 Nov; 159(5):1197-9. PubMed ID: 18764843
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides: cutaneous T-cell lymphoma.
Zaim MT; Grinkemeyer MD
Am Fam Physician; 1991 May; 43(5):1703-7. PubMed ID: 2021105
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
Johno M; Ono T
Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
[TBL] [Abstract][Full Text] [Related]
28. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.
Horwitz SM; Duvic M; Hsi ED
Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783
[TBL] [Abstract][Full Text] [Related]
29. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
30. Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides.
Bakels V; van Oostveen JW; Gordijn RL; Walboomers JM; Meijer CJ; Willemze R
Arch Dermatol; 1992 Dec; 128(12):1602-7. PubMed ID: 1456753
[TBL] [Abstract][Full Text] [Related]
31. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
32. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
Parker SR; Bethaney JV
G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
[TBL] [Abstract][Full Text] [Related]
34. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation.
Vu BA; Duvic M
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S16-22. PubMed ID: 18625371
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma.
Alessi E; Coggi A; Venegoni L; Merlo V; Gianotti R
Br J Dermatol; 2005 Aug; 153(2):368-71. PubMed ID: 16086751
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides.
Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R
J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398
[TBL] [Abstract][Full Text] [Related]
40. Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma.
Hodak E; Amitay I; Feinmesser M; Aviram A; David M
J Am Acad Dermatol; 2004 Mar; 50(3):368-74. PubMed ID: 14988677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
